These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 10899439)

  • 1. Oxidative stress in Alzheimer's disease.
    Smith MA; Rottkamp CA; Nunomura A; Raina AK; Perry G
    Biochim Biophys Acta; 2000 Jul; 1502(1):139-44. PubMed ID: 10899439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
    Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why nutraceuticals do not prevent or treat Alzheimer's disease.
    Fisher AE; Naughton DP
    Nutr J; 2005 Apr; 4():14. PubMed ID: 15826313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.
    Varadarajan S; Yatin S; Aksenova M; Butterfield DA
    J Struct Biol; 2000 Jun; 130(2-3):184-208. PubMed ID: 10940225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals.
    Sayre LM; Perry G; Harris PL; Liu Y; Schubert KA; Smith MA
    J Neurochem; 2000 Jan; 74(1):270-9. PubMed ID: 10617129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress hypothesis in Alzheimer's disease.
    Markesbery WR
    Free Radic Biol Med; 1997; 23(1):134-47. PubMed ID: 9165306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations on oxidative stress and therapeutical implications in dementia.
    Durany N; Münch G; Michel T; Riederer P
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():68-73. PubMed ID: 10654103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model.
    Drake J; Link CD; Butterfield DA
    Neurobiol Aging; 2003; 24(3):415-20. PubMed ID: 12600717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy.
    McLellan ME; Kajdasz ST; Hyman BT; Bacskai BJ
    J Neurosci; 2003 Mar; 23(6):2212-7. PubMed ID: 12657680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicellular hypothesis for the pathogenesis of Alzheimer's disease.
    Goetzl EJ; Miller BL
    FASEB J; 2017 May; 31(5):1792-1795. PubMed ID: 28100644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform.
    Kolaj I; Imindu Liyanage S; Weaver DF
    Neurochem Int; 2018 Nov; 120():99-111. PubMed ID: 30098379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime.
    Gamba P; Leonarduzzi G; Tamagno E; Guglielmotto M; Testa G; Sottero B; Gargiulo S; Biasi F; Mauro A; Viña J; Poli G
    Aging Cell; 2011 Jun; 10(3):403-17. PubMed ID: 21272192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [THE ROLE OF β-AMYLOID AND MITOCHONDRIAL DYSFUNCTION IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE].
    Szarka A
    Ideggyogy Sz; 2015 Jul; 68(7-8):222-8. PubMed ID: 26380416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The toxic conformation of the 42-residue amyloid beta peptide and its relevance to oxidative stress in Alzheimer's disease.
    Irie K; Murakami K; Masuda Y; Morimoto A; Ohigashi H; Hara H; Ohashi R; Takegoshi K; Fukuda H; Nagao M; Shimizu T; Shirasawa T
    Mini Rev Med Chem; 2007 Oct; 7(10):1001-8. PubMed ID: 17979802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.
    Butterfield DA; Lauderback CM
    Free Radic Biol Med; 2002 Jun; 32(11):1050-60. PubMed ID: 12031889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and amyloid beta toxicity in Alzheimer's disease: intervention in a complex relationship by antioxidants.
    Chakrabarti S; Sinha M; Thakurta IG; Banerjee P; Chattopadhyay M
    Curr Med Chem; 2013; 20(37):4648-64. PubMed ID: 23834172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress, antioxidants, and Alzheimer disease.
    Rottkamp CA; Nunomura A; Raina AK; Sayre LM; Perry G; Smith MA
    Alzheimer Dis Assoc Disord; 2000; 14 Suppl 1():S62-6. PubMed ID: 10850732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Power tools for Alzheimer's disease - an electrochemical preamp for Aβ.
    Zetterberg H; Hammarström P
    J Neurochem; 2012 Jul; 122(2):231-2. PubMed ID: 22409410
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42).
    Yatin SM; Varadarajan S; Link CD; Butterfield DA
    Neurobiol Aging; 1999; 20(3):325-30; discussion 339-42. PubMed ID: 10588580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.